________________________________________________________________________________ Conclusion: This study shows an high consistency of small field dosimetry in the involved radiotherapy departments using this new generation silicon diode; consequently, the values reported may actually be used by other centers as indicative values, especially in the case of small fields when suitable detector are not commonly available. Moreover, these results confirm that the new RAZOR silicon diode can be used to assess dosimetric accuracy in small-field delivery. In general, the adopted methodology removes much of the ambiguity in reporting and interpreting small field dosimetric quantities and facilitates a clear dosimetric comparison across a population of linacs. Purpose or Objective: Outlining of target and OAR volumes is integral to the radiotherapy process but inherently subject to variability. The hippocampus is a small structure not commonly contoured by clinicians requiring considered anatomical interpretation in its delineation. HIPPO is a randomised phase II trial of Hippocampal Sparing (HS) versus Conventional Whole Brain Radiotherapy after surgical resection or radiosurgery in favourable prognosis patients with 1-4 brain metastases. We set out to inform the development of a dedicated HIPPO RTQA programme through evaluation of hippocampal contouring.
Purpose or Objective:
Outlining of target and OAR volumes is integral to the radiotherapy process but inherently subject to variability. The hippocampus is a small structure not commonly contoured by clinicians requiring considered anatomical interpretation in its delineation. HIPPO is a randomised phase II trial of Hippocampal Sparing (HS) versus Conventional Whole Brain Radiotherapy after surgical resection or radiosurgery in favourable prognosis patients with 1-4 brain metastases. We set out to inform the development of a dedicated HIPPO RTQA programme through evaluation of hippocampal contouring.
Material and Methods:
Two clinical oncologists from different UK radiotherapy centres and a radiologist from each centre independently outlined the hippocampus on 2 different 1 mm slice thickness planning CT datasets after registration with the T1 weighted gadolinium enhanced MRI (3D volumetric MRI, axial acquisition, 1 mm slice thickness, no slice gap, 1 x 1 x 1 mm voxels) on their planning system. The datasets were re-registered by one of the centres. The four hippocampal contours for each case were anonymised and reviewed collectively and a gold standard contour defined. We compared each contour with its respective gold standard using the DICE coefficient and volume difference. Table 1 Conclusion: Reasonable concordance of the outlines in comparison to the gold standard was achieved in both cases. In case 1, all 4 outlines achieved a DICE coefficient greater than 0.80 and a hippocampal volume less than 0.5cm3 different to the gold standard. However, in case 2, despite DICE coefficients greater than 0.79 suggesting good spatial relationship between the clinicians' and the gold standard contour, greater variability was evident with a larger range in volume outlined. During collective review, some systematic differences were noted between the two participating centres' outlines, despite a high level of agreement on hippocampal boundaries during the review, highlighting CT-MRI co-registration as a potential source of variability between different centres and planning software. As a result of these findings, the pre-trial outlining benchmark case requires all centres to independently co-register the CT and MRI images and export the registration object as part of data submission. In order to comprehensively quality assure hippocampal outlining as part of the HIPPO RTQA programme, an on-trial component of the first two HS patient contours being reviewed prospectively before treatment is also undertaken. The implementation and quality assurance of less familiar outlining practice in the development of radiotherapy techniques requires careful consideration. This process has informed the development of a dedicated RTQA programme for the HIPPO trial highlighting the importance of aligning QA with clinical practice. HIPPO is funded by Cancer Research UK and The Brain Tumour Charity
Results:

EP-1950
Monte Carlo dose calculation of Viewray hybrid MRI-Co60 radiotherapy system: a repeatability study E. Placidi 
Material and Methods:
Ten patients affected by locally advanced rectal cancer (cT3-cT4; cN0, cN+) were manually segmented on Eclipse TPS v11. MRIdian step and shoot IMRT plans (7 groups of 3 fields each) were calculated 5 times for each patient. The prescribed dose for PTV2 was 45 Gy and 55 Gy for PTV1 through simultaneous integrated boost. The PTV1 V95, the conformity index CI [3] and the Wu's homogeneity index HI were computed for each patient. The coefficient of variation (CV), defined as the ratio of the standard deviation to the mean, was calculated for each set to express the precision and repeatability of the Monte Carlo dose calculation. The estimated beam-on time was also recorded for each plan.
Results:
The time for the optimization and the final dose calculation was less than 5 minutes for each plan having a total of 21 fields (7 groups of 3 heads). The mean CV for the conformity index was found to be equal to 1.6±0.5% whilst both the mean V95(PTV1) and the HI resulted in a CV smaller than 1%. The CV for the estimated beam-on time for the 10 patients was found to be 4.3±2.1% (mean±std). Purpose or Objective: Spine SBRT is an emerging treatment for patients with spinal metastases and rapidly being adopted in the clinic without treatment planning evaluation guidelines. Although the a priori treatment planning constraints were met in all cases in our previous study, large inter-institutional variations in 95% of the PTV volume (D95) and D50 were observed. The purpose of this study was to minimize the inter-institutional variations in planning.
Conclusion
Material and Methods:
Seven institutions in Japan, Canada, Singapore and USA participated and planned three cases with a total of ten apparatus. The spine cases included a 5th lumbar spine (case 1), 5th thoracic spine (case 2), and 10th thoracic spine metastases (case 3). Targets and organs at risk (OAR) were contoured by one experienced radiation oncologist according to International Spine Radiosurgery Consortium Consensus Guidelines and a 2 mm planning target volume (PTV) applied. The DICOM files were sent to each institute for planning. The treatment planning guidelines in the previous study included, prescribed dose of 24 Gy in two fractions with more than 70% prescribed dose to encompass D95, D0.035 &lt; 140% of the prescribed dose, and a maximum dose to the spinal cord planning organ at risk volume (PRV) or thecal sac &lt; 17 Gy. New guidelines added (D95 should be as high as possible(AHAP), D50 should be between 110% to 115% of prescribed dose and AHAP and D0.035 should be between 125% to 135% of the prescribed dose). The dose volume histograms (DVHs) were centrally reviewed.
Results: In our previous study the PTV D95 ranged from 70.0% to 99.6 % in case 1 (mean &plusmn; SD; 21.21 &plusmn; 2.43 Gy), 70.4% to 98.8% in case 2 (20.32 &plusmn; 2.22 Gy), and 70.0% to 94.2% in case 3 (19.78 &plusmn; 1.97 Gy), respectively and D50 for PTV ranged from 99.2% to 116.3% in case 1 (25.62 &plusmn; 1.34 Gy), 91.7% to 119.6% in case 2 (25.97 &plusmn; 2.18 Gy) and 84.2% to 114.2% in case 3 (25.57 &plusmn; 2.14 Gy), respectively. In this study PTV D95 ranged from 80.4% to 100.0% in case 1 (21.96 &plusmn; 1.67 Gy), 76.3% to 95.8% in case 2 (20.91 &plusmn; 1.67 Gy), and 70.4% to 94.2% in case 3 (20.3 &plusmn; 1.86 Gy), respectively and D50 for PTV ranged from 109.6% to 115.4% in case 1 (27.02 &plusmn; 0.53 Gy), 110.0% to 117.5% in case 2 (27.06 &plusmn; 0.63 Gy) and 107.5% to 115.0% in case 3 (26.89 &plusmn; 0.67 Gy), respectively.
Conclusion:
We succeeded to minimize the inter-institutional variations. This study highlights dose constraints of D95, D50 and D0.035 should be used to minimize the variations.
EP-1952
Monte-Carlo calculation of the secondary electron spectra inside and around gold nanoparticles E. Gargioni Purpose or Objective: The use of nanoparticles (NP) in cancer therapy has been intensively investigated in the last few years. The advantage of using metal NP (such as gold, platinum, silver, hafnium oxide) during radiotherapy is that the amount of secondary electrons produced by the primary particles is higher than for soft tissue. Due to this enhanced secondary-electron emission around NP, stronger DNA damage is caused in the surrounding cells. The enhancement of energy deposition around gold NP has been determined in a number of studies, often with contradictory results, thus showing that the absorbed dose is not the appropriate physical quantity to estimate DNA damage in the presence of gold. Therefore it is necessary to systematically investigate the dependence of DNA damage from the spectra of the emitted secondary electrons and from corresponding nanodosimetric parameters.
Material and Methods:
In this work, the secondary electron spectra produced inside and around gold NP were determined by means of Monte-Carlo simulations. The transport of secondary electrons created by different clinical photon sources inside and emerging from a NP surrounded by water was simulated using Geant4. The secondary electron spectrum inside gold NP of two different sizes (diameter: 12 and 30 nm) was calculated for mono-energetic photon sources (10 and 60 keV), an intra-operative x-ray source (maximum energy 50 keV), a conventional x-ray tube (200 keVp) and a clinical linear accelerator (6 MV).
Results:
The energy spectra of the secondary electrons created inside the NP have a mean energy varying between about 6 keV for the mono-energetic 10-keV photons and about 65 keV for the 6-MV spectrum. This corresponds to a decrease of the mean ionization cluster size of about a factor of four for the linear accelerator. Therefore a corresponding decrease of the number of induced DNA double strand breaks is expected. Moreover, the spectra inside and around the gold NP with a diameter of 12 nm barely distinguish from those inside the gold NP with a diameter of 30 nm. However, the total amount of secondary electrons emerging from the smaller gold NP is increased by about a factor of three.
Conclusion:
Further studies will be carried out in the future for determining the correlation between secondary electrons production and ionization cluster size distributions for other NP diameters and materials. Finally, a comparison between physical damage at nanometric level and cell survival experiments will be also performed.
